4//SEC Filing
ACADIA PHARMACEUTICALS INC 4
Accession 0001415889-14-000033
$ACADCIK 0001070494operating
Filed
Jan 2, 7:00 PM ET
Accepted
Jan 3, 7:03 PM ET
Size
12.0 KB
Accession
0001415889-14-000033
Insider Transaction Report
Form 4
Aasen Thomas H
Exec. VP, CFO & CBO
Transactions
- Gift
Common Stock
2014-01-02−30,000→ 31,348 total - Exercise/Conversion
Common Stock
2014-01-02$1.55/sh+22,000$34,100→ 61,348 total - Sale
Common Stock
2014-01-02$24.88/sh−30,000$746,334→ 0 total(indirect: By Trust) - Exercise/Conversion
Stock Option (right to buy)
2014-01-02−22,000→ 90,471 totalExercise: $1.55Exp: 2020-03-11→ Common Stock (22,000 underlying)
Footnotes (3)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in 2012.
- [F2]The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $24.50 to $25.01 per share, inclusive. The reporting person undertakes to provide ACADIA Pharmaceuticals Inc., any security holder of ACADIA Pharmaceuticals Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the foregoing range.
- [F3]25% of the shares subject to the Stock Option vested and became exercisable on March 12, 2011. The remaining shares vest and become exercisable thereafter in 36 equal monthly installments.
Documents
Issuer
ACADIA PHARMACEUTICALS INC
CIK 0001070494
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001070494
Filing Metadata
- Form type
- 4
- Filed
- Jan 2, 7:00 PM ET
- Accepted
- Jan 3, 7:03 PM ET
- Size
- 12.0 KB